Holen Sie sich die Stockscreener-App
53.58
4.66%
-2.495
Schlusskurs vom Vortag:
$56.07
Offen:
$55.02
24-Stunden-Volumen:
2.13M
Relative Volume:
1.52
Marktkapitalisierung:
$3.64B
Einnahmen:
$1.50B
Nettoeinkommen (Verlust:
$427.61M
KGV:
8.9143
EPS:
6.01
Netto-Cashflow:
$423.98M
1W Leistung:
-26.40%
1M Leistung:
-34.26%
6M Leistung:
-34.89%
1J Leistung:
-44.70%
1-Tages-Spanne:
$52.75
$55.65
1-Wochen-Bereich:
$47.25
$57.21
52-Wochen-Spanne:
$47.25
$118.21
Lantheus Holdings Inc Stock (LNTH) Company Profile
Firmenname
Lantheus Holdings Inc
Sektor
Telefon
978 671-8001
Adresse
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Vergleichen Sie LNTH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LNTH
Lantheus Holdings Inc
|
53.58 | 3.89B | 1.50B | 427.61M | 423.98M | 6.01 |
|
ZTS
Zoetis Inc
|
149.35 | 65.30B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.62 | 45.60B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.575 | 42.82B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.59 | 18.78B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
300.99 | 13.64B | 2.99B | 1.21B | 1.13B | 25.06 |
Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-18 | Eingeleitet | Goldman | Buy |
| 2024-09-03 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-07-10 | Bestätigt | JMP Securities | Mkt Outperform |
| 2023-12-18 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-12-04 | Eingeleitet | TD Cowen | Outperform |
| 2023-09-29 | Eingeleitet | William Blair | Outperform |
| 2023-03-08 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2022-11-30 | Eingeleitet | SVB Leerink | Outperform |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-05-09 | Eingeleitet | B. Riley Securities | Buy |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2021-02-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-29 | Fortgesetzt | Jefferies | Buy |
| 2019-08-16 | Hochstufung | CJS Securities | Market Perform → Market Outperform |
| 2017-11-02 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-11-08 | Bestätigt | RBC Capital Mkts | Outperform |
| 2016-09-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2016-02-24 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-12-11 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2015-09-30 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2015-07-20 | Eingeleitet | Credit Suisse | Outperform |
| 2015-07-20 | Eingeleitet | Jefferies | Buy |
| 2015-07-20 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2015-07-20 | Eingeleitet | Robert W. Baird | Outperform |
| 2015-07-20 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Lantheus Holdings Inc Aktie (LNTH) Neueste Nachrichten
LNTH ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Lantheus Holdings, Inc. - ACCESS Newswire
LNTH Q2 Deep Dive: Competitive Pressures and Guidance Cut Reshape Lantheus Outlook - Yahoo Finance
Lantheus downgraded to Hold at Truist on Pylarify uncertainty - MSN
Lantheus CCO Amanda Morgan Takes Leave of Absence - TipRanks
Truist Securities downgrades Lantheus stock to Hold on PYLARIFY concerns By Investing.com - Investing.com Canada
LNTH STOCK ALERT: Levi & Korsinsky Notifies Lantheus Holdings, Inc. Investors of an Ongoing Investigation - ACCESS Newswire
Lantheus Holdings (LNTH) Dives 28.6% on Tempered Growth Outlook - MSN
Lantheus lowers 2025 revenue and EPS outlook, targets $1.475B–$1.51B revenue as pricing pressures persist - MSN
Lantheus Holdings, Inc. (NASDAQ:LNTH) Q2 2025 Earnings Call Transcript - Insider Monkey
Lantheus Holdings, Inc. Just Reported A Surprise Profit And Analysts Updated Their Estimates - uk.finance.yahoo.com
Lantheus Holdings Inc’s Mixed Earnings Call: Challenges and Strategic Advances - TipRanks
Best Mid Cap Stocks To ResearchAugust 6th - MarketBeat
LNTH: Competition Escalates in PSMA Imaging - Zacks Small Cap Research
Goldman Sachs lowers Lantheus stock price target to $110 on Pylarify concerns - Investing.com Australia
Goldman Sachs lowers Lantheus stock price target to $110 on Pylarify concerns By Investing.com - Investing.com South Africa
Did Lantheus Holdings, Inc. (LNTH) Mislead Investors? Levi & Korsinsky Investigates - ACCESS Newswire
Lantheus Holdings: Mizuho Downgrades to Outperform, PT to $70 from $120. - AInvest
Lantheus (LNTH) shares plummet 33.1% to $48.62. - AInvest
Lantheus Holdings 2025 Q2 Earnings Earnings Surge 26.9% Despite Revenue Dip - AInvest
Lantheus Holdings shares rise 1.79% premarket after announcing a $400 million share repurchase program. - AInvest
Lantheus stock price target lowered to $73 at JMP on pricing pressure - Investing.com Australia
Lantheus Holdings (LNTH) Announces US$400 Million Buyback Amid FDA and Earnings Updates - simplywall.st
Lantheus Holdings Reports Q2 2025 Results and Strategic Moves - TipRanks
Lantheus Shares Tumble 28.58% on $700M Trading Surge to 143rd Rank as FDA Progress and Strategic Moves Unfold - AInvest
Lantheus Holdings shares rise 1.18% after-hours after announcing a $400 million share repurchase program. - AInvest
FDA accepts Lantheus’ NDA for new Pylarify formulation - AuntMinnie
Lantheus Holdings: Q2 Earnings Snapshot - Chron
Why Lantheus (LNTH) Stock Is Falling Today - Yahoo Finance
Lantheus Shares Slide As Earnings And Outlook Fall Short - Finimize
Tranche Update on Lantheus Holdings, Inc.'s Equity Buyback Plan announced on November 20, 2024. - MarketScreener
Lantheus Holdings, Inc. announces an Equity Buyback for $400 million worth of its shares. - MarketScreener
Lantheus Q2 2025 slides: revenue falls 4.1%, company slashes full-year guidance - Investing.com Canada
Lantheus Holdings: Reassessing The Buy Thesis (NASDAQ:LNTH) - Seeking Alpha
Lantheus Holdings stock hits 52-week low at $51.75 By Investing.com - Investing.com Australia
Lantheus Holdings stock hits 52-week low at $51.75 - Investing.com
Earnings call transcript: Lantheus Q2 2025 misses forecasts, shares plunge - Investing.com India
Earnings call transcript: Lantheus Q2 2025 misses forecasts, shares plunge By Investing.com - Investing.com Nigeria
Lantheus Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Lantheus announces FDA review for new radioactive imaging agent - MSN
Lantheus Holdings Inc Q2 2025 Earnings: EPS Surges to $1.12, Bea - GuruFocus
Lantheus Holdings Inc earnings missed by $0.10, revenue fell short of estimates - Investing.com
Lantheus Q2 Adjusted Earnings, Revenue Fall; Lowers 2025 Guidance; Shares Drop Pre-Bell - MarketScreener
Lantheus Holdings Plunges 22.21% on Missed Q2 Earnings - AInvest
Lantheus Announces FDA Acceptance of New Drug Application - TipRanks
Lantheus (NASDAQ:LNTH) Reports Sales Below Analyst Estimates In Q2 Earnings, Stock Drops 20.8% - Yahoo Finance
Lantheus Holdings, Inc. SEC 10-Q Report - TradingView
Why Lantheus Shares Are Taking a Hit - TipRanks
Lantheus stock slips on Q2 miss amid regulatory win (LNTH) - Seeking Alpha
FDA accepts Lantheus’ NDA for new PSMA PET imaging formulation By Investing.com - Investing.com Nigeria
FDA accepts Lantheus’ NDA for new PSMA PET imaging formulation - Investing.com India
Riley Reduces Lantheus Holdings (LNTH) PT to $109, Maintains Buy Rating - MSN
Finanzdaten der Lantheus Holdings Inc-Aktie (LNTH)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):